Drreddys Laboratories | Bruttoavancen På Salg



Gross Profit On Sales Lave om Dato
ANI Pharmaceuticals USD 110.29M 134.46M 2024-12
Aurora Cannabis CAD 9.35M 6.18M 2024-12
Bayer EUR 6.01B 1.13B 2024-12
Canopy Growth CAD 24.1M 2.26M 2024-12
Cipla INR 50.3B 3.52B 2024-12
Corcept Therapeutics USD 178.93M 745K 2024-12
Drreddys Laboratories INR 49.05B 1.28B 2024-12
GlaxoSmithKline GBP 5.56B 57M 2024-12
Hikma Pharmaceutical USD 756M 82M 2024-06
Lonza CHF 1.12B 276M 2024-06
Novartis USD 10.23B 294M 2024-12
Pacira USD 147.37M 17.66M 2024-12
Prestige Brands USD 161.05M 3.67M 2024-12
Richter Gedeon HUF 147.67B 5.55B 2024-09
Sun Pharmaceuticals INR 109.35B 3.65B 2024-12
Supernus Pharmaceuticals USD 156.96M 1.14M 2024-12
Teva Pharmaceutical Industries USD 2.12B 85M 2024-12



Drreddys Laboratories Bruttoavancen På Salg - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.